Chad vs Uzbekistan: Treatment success rate for patients treated for MDR-TB
Chad
73.0%
in 2022
Uzbekistan
73.0%
in 2021
Chad rank
83rd
Uzbekistan rank
83rd
Treatment success rate for patients treated for MDR-TB over time
- Chad
- Uzbekistan
How they compare
Chad currently reports 73.0% against 73.0% in Uzbekistan, a difference of 0.0%.
The two have swapped places 2 times across 8 shared years of data; in 2014 it was Uzbekistan ahead.
Chad ranks 83rd and Uzbekistan ranks 83rd of 163 countries.
Uzbekistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chad | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 54.5% | 62.7% | 8.2% | Uzbekistan |
| 2020s | 62.0% | 72.5% | 10.5% | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Chad or Uzbekistan?
- Chad, at 73.0% against 73.0% in Uzbekistan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Chad and Uzbekistan?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Uzbekistan?
- 8 years are reported by both, from 2014 to 2021.
- How do Chad and Uzbekistan rank globally for treatment success rate for patients treated for mdr-tb?
- Chad ranks 83rd and Uzbekistan ranks 83rd of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.